First Report Managed Care - Home
“Ultimately, the changes we are proposing would reduce costs for protected class medicines,” said Seema Verma, Centers for Medicare and Medicaid Services administrator, “and therefore expand access to these important medicines.”
| Read More
The National Committee for Quality Assurance has certified ELEVATE! Quality Insights software by Advantmed, LLC, an integrated risk-adjustment optimization and quality improvement company, for 2019 HEDIS hybrid measures.
| Read More
Less than 40% of individuals with familial hypercholesterolemia (FH) receive appropriate high-intensity statin therapy, according to new research.
| Read More
Low and high concentrations of high-density lipoprotein cholesterol (HDL-C) may be associated with an increased risk of infectious disease in the general population, according to new findings.
| Read More
